Pancreatitis, Chronic
|
0.330 |
Biomarker
|
disease |
BEFREE |
It has previously been reported in a European case-control study with patients from Germany and France that CEL-HYB1, a hybrid allele of the carboxyl ester lipase (CEL) gene and its pseudogene CELP, increases susceptibility to chronic pancreatitis (CP).
|
31036489 |
2019 |
Pancreatitis, Chronic
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
A hybrid allele between the carboxyl ester lipase gene (CEL) and its pseudogene, CELP (called CEL-HYB), generated by nonallelic homologous recombination between CEL intron 10 and CELP intron 10', was found to increase susceptibility to chronic pancreatitis in a case-control study of patients of European ancestry.
|
26946345 |
2016 |
Pancreatitis, Chronic
|
0.330 |
Biomarker
|
disease |
CTD_human |
A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis.
|
25774637 |
2015 |
Pancreatitis, Chronic
|
0.330 |
Biomarker
|
disease |
BEFREE |
A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis.
|
25774637 |
2015 |
Carcinogenesis
|
0.030 |
GeneticVariation
|
phenotype |
BEFREE |
We established a new choriocarcinoma cell line, induced choriocarcinoma cell-1 (iC3-1), which mimics the clinical pathohistology in vivo, to examine the tumorigenesis and pathogenesis of choriocarcinoma.
|
24424471 |
2014 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
In this study, to clarify the genetic characteristics of iC(3)-1 and to explore the tumorigenesis mechanism, we examined the gene profile of iC(3)-1 compared to those of existing cell lines and normal placental tissue.
|
23199791 |
2013 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
At cellular level, what we have achieved is the shifting of the Stem Cell 1 population, highly susceptible to cancer, to a population of Stem Cell 2 that is refractory to carcinogenesis.
|
17882673 |
2007 |
Choriocarcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
In this study, the alterations of glycan structures in the development of choriocarcinoma were examined by performance of comprehensive glycan profiling in clinical samples and in iC3-1 cells using a conventional microarray and the recently introduced lectin microarray.
|
24424471 |
2014 |
Choriocarcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
In summary, the gene expression profile of iC(3)-1 suggests that studies using this cell line can make an important contribution to improved understanding of choriocarcinoma tumorigenesis.
|
23199791 |
2013 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
At cellular level, what we have achieved is the shifting of the Stem Cell 1 population, highly susceptible to cancer, to a population of Stem Cell 2 that is refractory to carcinogenesis.
|
17882673 |
2007 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
At cellular level, what we have achieved is the shifting of the Stem Cell 1 population, highly susceptible to cancer, to a population of Stem Cell 2 that is refractory to carcinogenesis.
|
17882673 |
2007 |
Malignant Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
(2002) Cancer Cell 1, 19-30), little is known about the signaling pathways leading to changes in the apoptotic threshold in cancer cells.
|
14766752 |
2004 |
Primary malignant neoplasm
|
0.020 |
Biomarker
|
group |
BEFREE |
(2002) Cancer Cell 1, 19-30), little is known about the signaling pathways leading to changes in the apoptotic threshold in cancer cells.
|
14766752 |
2004 |
Respiratory syncytial virus bronchiolitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Increased T-helper Cell 2 Response in Infants With Respiratory Syncytial Virus Bronchiolitis Hospitalized Outside Epidemic Peak.
|
31815840 |
2020 |
Giardiasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Increased Innate Lymphoid Cell 3 and IL-17 Production in Mouse Lamina Propria Stimulated with Giardia lamblia.
|
31284344 |
2019 |
Hemochromatosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Haemochromatosis: Pathophysiology and the red blood cell1.
|
29660923 |
2018 |
Ankylosing spondylitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor-Like Molecule 1A+Interleukin-23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune Functions.
|
29869839 |
2018 |
Invasive Pulmonary Aspergillosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Role of Triggering Receptor Expressed on Myeloid Cell-1 Expression in Mammalian Target of Rapamycin Modulation of CD8<sup>+</sup> T-cell Differentiation during the Immune Response to Invasive Pulmonary Aspergillosis.
|
28485322 |
2017 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Among HPV16-positive patients with oropharyngeal carcinoma, metastases to regional lymph nodes were observed in 100 % (17/17) and 68 % (40/58) for those with <1 HPV16 copy cell-1 and >1 HPV16 copy cell-1, respectively (P=0.007).
|
27667722 |
2016 |
Oropharyngeal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Among HPV16-positive patients with oropharyngeal carcinoma, metastases to regional lymph nodes were observed in 100 % (17/17) and 68 % (40/58) for those with <1 HPV16 copy cell-1 and >1 HPV16 copy cell-1, respectively (P=0.007).
|
27667722 |
2016 |
Secondary Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Among HPV16-positive patients with oropharyngeal carcinoma, metastases to regional lymph nodes were observed in 100 % (17/17) and 68 % (40/58) for those with <1 HPV16 copy cell-1 and >1 HPV16 copy cell-1, respectively (P=0.007).
|
27667722 |
2016 |
Mixed follicular and papillary thyroid carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
|
20450430 |
2010 |
Pneumonia, Ventilator-Associated
|
0.010 |
Biomarker
|
disease |
BEFREE |
Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report.
|
17505044 |
2007 |
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Seven of 9 alterations in p16/CDKN2 and p15/MTS2 were observed in serous (3 of 12), endometrioid (3 of 9) and clear-cell (1 of 4) carcinomas.
|
8980248 |
1996 |